Sermorelin & GHRP-2 Blend (10mg)
Sermorelin 5 mg / GHRP-2 5 mg provides a high-purity, laboratory-verified lyophilized peptide blend manufactured under strict quality control standards in the USA. Formulated as a dual-action secretagogue complex, each vial combines 5 mg of Sermorelin (a synthetic 29-amino-acid analog of Growth Hormone-Releasing Hormone) with 5 mg of GHRP-2 (Growth Hormone-Releasing Peptide-2, a synthetic ghrelin receptor agonist). This blend is widely utilized in endocrinology, somatotropic axis dynamics, and metabolic research examining synergistic GH pulse amplification, pituitary somatotroph receptor interaction, and circulating IGF-1 elevation.
Key Specifications
Active Compounds: Sermorelin (GHRH 1-29) & GHRP-2 (Pralmorelin)
Blend Ratio / Concentration: 5 mg Sermorelin + 5 mg GHRP-2 (10 mg total per vial)
Chemical Formulas: \text{C}_{149}\text{H}_{246}\text{N}_{44}\text{O}_{42} (Sermorelin) / \text{C}_{45}\text{H}_{55}\text{N}_{9}\text{O}_{6} (GHRP-2)
Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Formulation: Sterile Lyophilized Powder
Origin: Manufactured in USA
Classification: Research Use Only
Primary Research Applications
Dual-Mechanism GH Secretion Synergy: Combines GHRH receptor stimulation (Sermorelin) with ghrelin/growth hormone secretagogue receptor (GHS-R) binding (GHRP-2) to analyze supra-additive pituitary growth hormone pulsatility.
Somatotropic Axis & IGF-1 Dynamics: Extensively evaluated in endocrine research models measuring downstream serum IGF-1 upregulation, nitrogen retention, and cellular protein synthesis signaling.
Metabolic Rate & Lipid Oxidation: Investigated in body composition models to assess lipolysis mechanisms, visceral fat metabolism, and recovery dynamics following cellular stress.
Sermorelin & GHRP-6 & GHRP-2 Blend (9mg)
Sermorelin 5 mg / GHRP-2 5 mg provides a high-purity, laboratory-verified lyophilized peptide blend manufactured under strict quality control standards in the USA. Formulated as a dual-action secretagogue complex, each vial combines 5 mg of Sermorelin (a synthetic 29-amino-acid analog of Growth Hormone-Releasing Hormone) with 5 mg of GHRP-2 (Growth Hormone-Releasing Peptide-2, a synthetic ghrelin receptor agonist). This blend is widely utilized in endocrinology, somatotropic axis dynamics, and metabolic research examining synergistic GH pulse amplification, pituitary somatotroph receptor interaction, and circulating IGF-1 elevation.
Key Specifications
Ā Active Compounds: Sermorelin (GHRH 1-29) & GHRP-2 (Pralmorelin)
Ā Blend Ratio / Concentration: 5 mg Sermorelin + 5 mg GHRP-2 (10 mg total per vial)
Ā Chemical Formulas: \text{C}_{149}\text{H}_{246}\text{N}_{44}\text{O}_{42} (Sermorelin) / \text{C}_{45}\text{H}_{55}\text{N}_{9}\text{O}_{6} (GHRP-2)
Ā Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā Dual-Mechanism GH Secretion Synergy: Combines GHRH receptor stimulation (Sermorelin) with ghrelin/growth hormone secretagogue receptor (GHS-R) binding (GHRP-2) to analyze supra-additive pituitary growth hormone pulsatility.
Ā Somatotropic Axis & IGF-1 Dynamics: Extensively evaluated in endocrine research models measuring downstream serum IGF-1 upregulation, nitrogen retention, and cellular protein synthesis signaling.
Ā Metabolic Rate & Lipid Oxidation: Investigated in body composition models to assess lipolysis mechanisms, visceral fat metabolism, and recovery dynamics following cellular stress.